Printer Friendly

JOHNSON & JOHNSON-PROJECT HOPE NURSING CLINICAL CENTERS OF EXCELLENCE PROGRAM TO BE CREATED IN CENTRAL EUROPE

      JOHNSON & JOHNSON-PROJECT HOPE NURSING CLINICAL CENTERS
       OF EXCELLENCE PROGRAM TO BE CREATED IN CENTRAL EUROPE
    MILLWOOD, Va., Feb. 21 /PRNewswire/ -- Nursing education and practice in Central Europe will be strengthened through a system of Nursing Clinical Centers of Excellence to be established by the international health education foundation Project HOPE, with funding from Johnson & Johnson.
    The program, part of Projects HOPE's overall nursing practice and education initiatives in Eastern Europe, focuses on the development of model clinics in Czechoslovakia, Hungary and Poland.  Four Johnson & Johnson-Project HOPE Nursing Clinical Centers of Excellence will be established as models of quality clinical practice and patient management, and will provide the professional environment necessary for clinical education.
    "With the support of Johnson & Johnson, Project HOPE is assisting the Ministries of Health in these countries to provide quality care in their newly reforming health care systems," said Project HOPE nursing director Carolyn C. Krugner, R.N., Ph.D.  "We are helping the nursing leadership to plan new models of nursing education, introducing nursing faculty to contemporary concepts of professional nursing, and developing the curricula and educational materials to support them.
    "The Johnson & Johnson-Project HOPE Nursing Clinical Care Centers of Excellence will become training centers for nursing schools, and for practicing nurses from hospitals and clinics in the surrounding regions," Kruger said.  "They will be models of clinical nursing practice and quality patient care, and an environment for clinical education and research."
    Johnson & Johnson, based in New Brunswick, N.J., is providing a three-year, $300,000 grant to Project HOPE for the project.  The company is the world's largest manufacturer of health care products serving the consumer, professional and pharmaceutical markets, and was founded more than a century ago.
    "Johnson & Johnson has been a leader in providing nursing management education in the United States and in other parts of the world," said William Dearstyne, Johnson & Johnson company group chairman.  "The decision to work in partnership with Project HOPE further underscores our belief in nursing as a critical component in an effective health care system."
    The Clinical Centers of Excellence build on Project Hope nursing education efforts in Central Europe which began as the region opened and officials requested assistance in health education.  Leading HOPE's new initiatives in nursing education was an international nursing symposium held last May in Bratislava, Czechoslovakia, at which nursing leaders from across Central Europe were introduced to varied  educational methods and curricula, and encouraged to share ideas.
    New model baccalaureate nursing programs which Project HOPE is now helping to establish in Czechoslovakia and Hungary, as well as longstanding Project HOPE nursing education programs in Poland, will support improvements demonstrated through the Johnson & Johnson-Project HOPE Nursing Clinical Centers of Excellence.  In addition, in collaboration with health officials and nursing leaders in the three countries, an International Nursing Clinical Education Committee is being formed to develop, monitor, and evaluate the clinical and educational progress of the centers.
    Also in connection with the centers, Project HOPE will implement a clinical educator preparation program to train a core group of educators for the region, and develop continuing education programs for practicing nurses.  International symposia will be coordinated to address nursing issues related to the development of clinical centers.
    Project HOPE, the primary activity of The People-to-People Health Foundation Inc., currently operates programs in 28 countries, including the United States.  The Foundation was established in 1958 and has offices in Washington and San Francisco and headquarters in Millwood.
    -0-                            2/21/92
    /CONTACT:  Shaun P. Mickus of Johnson & Johnson, 908-524-3352, or Maggie Wolff Peterson of Project HOPE, 703-837-2100/ CO:  Johnson & Johnson; Project HOPE ST:  New Jersey, Virginia IN:  HEA SU: SM-AH -- NY047 -- 1473 02/21/92 15:27 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 21, 1992
Words:612
Previous Article:WESTINGHOUSE ENGINEERS CHALLENGE STUDENTS TO DISCOVER 'E'
Next Article:GEORGIA POWER $2.9 BILLION FIRST MORTGAGE BONDS RAISED TO 'A-' BY FITCH -- FITCH FINANCIAL WIRE --
Topics:


Related Articles
Viragen Names Kenneth Johnson, M.D., Leading Multiple Sclerosis Clinician, As Senior Medical Advisor for MS/Neurology
Secretary Honors Top Nurses.
GMP Companies, Inc. Announces New Management Appointments; Peter Feig, M.D., Joins as Vice President of Clinical Development and Caron D'Ambruso...
Johnson & Johnson; Statewide Coalition to Address New Jersey Nursing Shortage; Program Provides Nursing Student Scholarships, Nursing Faculty...
Johnson & Johnson; Southern California Healthcare Coalition Address Area Nursing Shortage; Program Provides Nursing Student Scholarships, Nursing...
Johnson & Johnson Pharmaceutical Research & Development Powers R&D Facility Expansion With New 'Green' Cogeneration System; Green Power Project Gets...
NCHL Leadership Development Study to Focus on Nursing Within Senior Leadership Teams of Healthcare Organizations.
Vertex Pharmaceuticals and Janssen Pharmaceutica, a Johnson & Johnson Company, Form Collaboration to Develop and Commercialize VX-950 for Treatment...
Vertex Pharmaceuticals and Janssen Pharmaceutica, a Johnson & Johnson Company, Form Collaboration to Develop and Commercialize VX-950 for Treatment...
New Dartmouth seed program targets med tech ventures.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters